|
Volumn 295, Issue 5557, 2002, Pages
|
Tissue engineering - Current challenges and expanding opportunities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL ORGANS;
DRUG PRODUCTS;
PATIENT TREATMENT;
TRANSPLANTS;
TISSUE ENGINEERING;
TISSUE;
BIOMATERIAL;
FIBROBLAST GROWTH FACTOR;
PLATELET DERIVED GROWTH FACTOR;
VASCULOTROPIN;
BIOCHEMISTRY;
BIOTECHNOLOGY;
CELL TRANSPLANTATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MICROCIRCULATION;
NONHUMAN;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
REVIEW;
SAFETY;
TISSUE ENGINEERING;
XENOTRANSPLANTATION;
ANIMALS;
BIOCOMPATIBLE MATERIALS;
BIOREACTORS;
BLOOD VESSELS;
CELL CULTURE TECHNIQUES;
CELL DIFFERENTIATION;
CULTURE TECHNIQUES;
EMBRYO;
HUMANS;
MODELS, BIOLOGICAL;
NEOVASCULARIZATION, PHYSIOLOGIC;
SKIN TRANSPLANTATION;
STEM CELLS;
TISSUE ENGINEERING;
|
EID: 18244366662
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1069210 Document Type: Review |
Times cited : (2070)
|
References (62)
|